FDA Inspection 1003899 — Syntho Pharmaceuticals, Inc.
The FDA completed an inspection of Syntho Pharmaceuticals, Inc. on Mar 9, 2017 in Farmingdale, NY. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Mar 9, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Farmingdale, NY (United States)